According to TipRanks.com, Chen is a 5-star analyst with an average return of 29.5% and a 38.3% success rate. Chen covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Interpace Diagnostics Group, and HTG Molecular Diagnostics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Greenwich LifeSciences with a $78.00 average price target.
Greenwich LifeSciences’ market cap is currently $421.4M and has a P/E ratio of -105.60. The company has a Price to Book ratio of 15.62.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.
Read More on GLSI: